Peripheral neuropathic pain,
Conditions
Interventions
pain reduction post lidocaine infusion,
pain reduction post oxcarbazepine
Treatment
oral oxcarbazepine
Sponsors
Siriraj Research and Development Fund
Siriraj Clinical Pain Management Training Centre
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Have a symptom of peripheral neuropathic pain 2.Age 18 - 65 years 3.Have pain score numerical rating scales (NRS)>5
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Pregnancy, 2) Previous carbarmazepine, oxcarbazepine and lidocaine treatment, 3) Allergy to oxcarbazepine, carbamazepine or lidocaine, 4) Patient with cancer, 5) Patient with impaired mental status or psychosis. 6) Patient with uncontrolled medical conditions such as Child-Pugh B, CrCl<50 ml/min, arrhythmia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain reduction post lidocaine,post oxcarbazepine 3 time point, baseline, post lidocaine, post oxcarbazepine Numerical rating scale baseline,post lidocaine infusion and posy oxcarbazepine | — |
Secondary
| Measure | Time frame |
|---|---|
| evaluate the efficacy and side effects of oxcarbazepine in peripheral neuropathic pain post oxcarbazepine side effect of oxcarbazepine | — |
Countries
Thailand
Contacts
Public ContactPramote Euasobhon
Siriraj Clinical Pain Management Training Centre
Outcome results
None listed